Research Webinars

What does COVID-19 have to do with the brain?


COVID-19 syndrome includes neurological symptoms in over 30% of patients. This webinar will address molecular approaches from both cellular and organismal viewpoints. How SARS-COV-2 affects the human brain is an important approach to developing diagnostics, and then therapeutic agents, to help patients.

Luiz Eugênio Mello
Scientific Director, FAPESP 

Daniel Martins-de-Souza
University of Campinas (UNICAMP) and FAPESP

Helena Radbruch
Charité Universitaetsmedizin Berlin 

Marcelo Mori
University of Campinas (UNICAMP) 

Jean Pierre Peron
Institute of Biomedical Sciences, University of São Paulo (ICB/USP)

Marília Zaluar Guimarães 
D’Or Institute for Research and Education (IDOR) 
and Federal University of Rio de Janeiro (UFRJ)


There will be no certificate/declaration of presence
for events broadcast on YouTube.

You can participate in a Q & A panel. Please, send your comments
and questions (in English or Portuguese) to live@fapesp.br.


Supported by: